Johanna Rostin - Oasmia Pharmaceutical Head Affairs
| OASMYDelisted Stock | USD 0.06 0.00 0.00% |
Insider
Johanna Rostin is Head Affairs of Oasmia Pharmaceutical AB
| Age | 56 |
| Phone | 46 18 50 54 40 |
| Web | https://www.vivesto.com |
Oasmia Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of (0.0875) % which means that it has lost $0.0875 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2542) %, meaning that it generated substantial loss on money invested by shareholders. Oasmia Pharmaceutical's management efficiency ratios could be used to measure how well Oasmia Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Julianne Canavaggio | Copa Holdings SA | ||
| Melinda McAfee | Victorias Secret Co | 53 | |
| Michael Blackford | Canada Goose Holdings | 55 | |
| Raul Pascual | Copa Holdings SA | N/A | |
| Donna James | Victorias Secret Co | 63 | |
| Daniel Gelemovich | Volaris | N/A | |
| Lauren Peters | Victorias Secret Co | 59 | |
| Peter Donkersloot | Copa Holdings SA | 36 | |
| Sarah Davis | Victorias Secret Co | 53 | |
| Alain Bellemare | Delta Air Lines | 63 | |
| Anne Sheehan | Victorias Secret Co | 63 | |
| Diana BirkettRakow | Alaska Air Group | 46 | |
| Paul Cadman | Canada Goose Holdings | 66 | |
| Jacqueline Hernandez | Victorias Secret Co | 54 | |
| Eric Westerby | Canada Goose Holdings | 48 | |
| Monica Bernal | Volaris | 42 | |
| Isela Cervantes | Volaris | 40 | |
| Brian Leinbach | Victorias Secret Co | N/A | |
| Guadalupe Margain | Volaris | 49 | |
| Irene Britt | Victorias Secret Co | 58 | |
| Jose Gutierrez | Volaris | 57 | |
Management Performance
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0875 |
Oasmia Pharmaceutical Leadership Team
Elected by the shareholders, the Oasmia Pharmaceutical's board of directors comprises two types of representatives: Oasmia Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oasmia. The board's role is to monitor Oasmia Pharmaceutical's management team and ensure that shareholders' interests are well served. Oasmia Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oasmia Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kai Wilkinson, Chief Officer | ||
| Urban Ekelund, IR Mang | ||
| Henrik Rnnberg, Chief Health | ||
| John Cosby, Head Affairs | ||
| Robert Maiorana, Head CFO | ||
| Dzianis Babrou, Head Devel | ||
| Christer MD, Acting Officer | ||
| Reinhard Koenig, Chief Officer | ||
| Johanna Rostin, Head Affairs | ||
| Maria Hagberg, Head Affairs |
Oasmia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Oasmia Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0875 | ||||
| Current Valuation | 6.58 M | ||||
| Shares Outstanding | 179.35 M | ||||
| Number Of Shares Shorted | 20.72 K | ||||
| Price To Book | 0.68 X | ||||
| Price To Sales | 31.16 X | ||||
| Revenue | 26.19 M | ||||
| Gross Profit | (15.25 M) | ||||
| EBITDA | (97.54 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |